Literature DB >> 14684512

Providing optimal radiology service in the severe acute respiratory syndrome outbreak: use of mobile CT.

Hemant A Parmar1, Tchoyoson C C Lim, Jeffrey Seow-Kuang Goh, Jau Tsair Tan, Yih Yian Sitoh, Francis Hui.   

Abstract

OBJECTIVE: Severe acute respiratory syndrome (SARS) is a serious atypical pneumonia caused by a novel pathogen. We describe our experience using a mobile CT scanner in an improvised isolation ward with life-support systems, portable lead shielding, and strict barrier nursing. This scanner was used exclusively for patients with SARS and patients with other illnesses who were also thought to have SARS. This arrangement freed the other CT scanners in the main department for non-SARS patients. In 5 weeks, 90 studies were performed; no cases of cross infection of health care workers were reported.
CONCLUSION: Mobile CT may be used to provide dedicated radiology services to seriously ill patients requiring strict isolation during an infectious disease outbreak.

Entities:  

Mesh:

Year:  2004        PMID: 14684512     DOI: 10.2214/ajr.182.1.1820057

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path.

Authors:  Roberto Stramare; Giovanni Carretta; Alfio Capizzi; Deris Gianni Boemo; Cristina Contessa; Raffaella Motta; Giorgio De Conti; Francesco Causin; Chiara Giraudo; Daniele Donato
Journal:  Radiol Med       Date:  2020-06-04       Impact factor: 3.469

Review 2.  A Concise Review and Required Precautions for COVID-19 Outbreak in Diagnostic and Interventional Radiology.

Authors:  Ali Kord; Behnam Rabiee; Siwen Wang; Sara Rostami; Ron C Gaba; Karen L Xie
Journal:  Radiol Res Pract       Date:  2020-07-22

Review 3.  Planning and coordination of the radiological response to the coronavirus disease 2019 (COVID-19) pandemic: the Singapore experience.

Authors:  I Y Y Tsou; C J Y Liew; B P Tan; H Chou; S B S Wong; K S H Loke; R C W Quah; A G S Tan; K H Tay
Journal:  Clin Radiol       Date:  2020-04-11       Impact factor: 2.350

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.